Delivery of a Therapeutic Protein by Immune-Privileged Sertoli Cells
Immune-privileged Sertoli cells survive long term after allogeneic or xenogeneic transplantation without the use of immunosuppressive drugs, suggesting they could be used as a vehicle to deliver therapeutic proteins. As a model to test this, we engineered Sertoli cells to transiently produce basal l...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2010-12-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.3727/096368910X516628 |